EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Open Access

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020

Ekaterina V Kurbatova, William C Whitworth, Kia E Bryant, Meredith G Dixon, Kelly E Dooley, Nigel A Scott, Rosanna Boyd, Nicole E Brown, Kimberley N Chapman Hedges, Wendy Carr, Lakshmi P Peddareddy, Grace Muzanyi und 11 weitere

Emerging Infectious Diseases · 2025-12 · 31 (12) · 2233-2242

DOI: 10.3201/eid3112.250492 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Emerging Infectious Diseases, 2025-12. Verfasst von Ekaterina V Kurbatova und 22 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pregnancy Outcome, Tuberculosis, Pregnancy Complications, Infectious, Antitubercular Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomeTuberculosisPregnancy Complications, InfectiousAntitubercular AgentsHumansFemalePregnancyAdultRifampinYoung AdultInfant, Newborn

Stichwörter der Autor:innen

bacteriacongenital anomalydrug-susceptible tuberculosis treatmentfetal losspregnancy outcomesrifapentinetuberculosis and other mycobacteria

Substanzen

Antitubercular AgentsRifampinrifapentine

Förderung

  • NIAID NIH HHS

Zitieren

APA

Kurbatova, E. V., Whitworth, W. C., Bryant, K. E., Dixon, M. G., Dooley, K. E., Scott, N. A., Boyd, R., Brown, N. E., Chapman Hedges, K. N., Carr, W., Peddareddy, L. P., Muzanyi, G., Dawson, R., Waja, Z., Martinson, N., Mathad, J. S. V., Nahid, P., Swindells, S., Chaisson, R. E., …, & Tuberculosis Trials Consortium Study 31 (2025). Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020. Emerging Infectious Diseases, 31(12), 2233-2242. https://doi.org/10.3201/eid3112.250492

Vancouver

Kurbatova EV, Whitworth WC, Bryant KE, Dixon MG, Dooley KE, Scott NA, et al. Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020. Emerging Infectious Diseases. 2025;31(12):2233-2242. doi:10.3201/eid3112.250492

BibTeX
@article{Kurbatova2025,
  author = {Kurbatova, Ekaterina V and Whitworth, William C and Bryant, Kia E and Dixon, Meredith G and Dooley, Kelly E and Scott, Nigel A and Boyd, Rosanna and Brown, Nicole E and Chapman Hedges, Kimberley N and Carr, Wendy and Peddareddy, Lakshmi P and Muzanyi, Grace and Dawson, Rodney and Waja, Ziyad and Martinson, Neil and Mathad, Jyoti S V and Nahid, Payam and Swindells, Susan and Chaisson, Richard E and Dorman, Susan E and Phillips, Patrick P J and AIDS Clinical Trials Group A5349,, AIDS Clinical Trials Group A5349, and Tuberculosis Trials Consortium Study 31, Tuberculosis Trials Consortium Study 31},
  title = {Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020},
  journal = {Emerging Infectious Diseases},
  year = {2025},
  volume = {31},
  number = {12},
  pages = {2233--2242},
  doi = {10.3201/eid3112.250492}
}
Kostenlos starten →